Erratum for: Pneumococcal capsules and their types: Past, present, and future (Clin Microbiol Rev, (2015) 28, 3, (871–899), 10.1128/CMR.00024-15);Pneumococcal capsules and their types: Past, present, and future

Clinical Microbiology Reviews

Volumn 28, Issue 3, 2015, Pages 871-899

  Geno, K Aaron ^a   Gilbert, Gwendolyn L ^b,c   Song, Joon Young ^d   Skovsted, Ian C ^e   Klugman, Keith P ^f   Jones, Christopher ^g   Konradsen, Helle B ^e   Nahm, Moon H ^a,h  

^a University of Alabama at Birmingham   (United States)

^b WESTMEAD HOSPITAL   (Australia)

^c University of Sydney   (Australia)

^d Korea University College of Medicine   (South Korea)

^e STATENS SERUM INSTITUT   (Denmark)

^f BILL AND MELINDA GATES FOUNDATION   (United States)

^g NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^h University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL CAPSULE; BACTERIAL VIRULENCE; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GAS LIQUID CHROMATOGRAPHY; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; INNATE IMMUNITY; MASS SPECTROMETRY; NEXT GENERATION SEQUENCING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PNEUMOCOCCAL INFECTION; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; BACTERIAL GENOME; GENETICS; IMMUNOLOGY; PATHOGENICITY; STANDARDS;

STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL CAPSULES; BACTERIAL VACCINES; GENOME, BACTERIAL; IMMUNITY, INNATE; POLYSACCHARIDES, BACTERIAL; SEROGROUP; STREPTOCOCCUS PNEUMONIAE;

EID: 84933502798     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00320-20     Document Type: Erratum

References (290)

1. White B. 1938. The biology of pneumococcus. The Commonwealth Fund, New York, NY.
2. Morens DM, Taubenberger JK, Fauci AS. 2008. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198:962–970. http://dx.doi.org/10.1086/591708.
3. Verma R, Khanna P. 2012. Pneumococcal conjugate vaccine: a newer vaccine available in India. Hum Vaccin Immunother 8:1317–1320. http://dx.doi.org/10.4161/hv.20654.
4. World Health Organization. 2012. Pneumococcal vaccines. WHO position paper—2012—recommendations. Vaccine 30:4717–4718. http://dx.doi.org/10.1016/j.vaccine.2012.04.093.
5. World Health Organization. 2007. Pneumococcal conjugate vaccine for childhood immunization—WHO position paper. Wkly Epidemiol Rec 82:93–104.
6. O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, Hib and Pneumococcal Global Burden of Disease Study Team. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893–902. http://dx.doi.org/10.1016/S0140-6736(09)61204-6.
7. World Health Organization. 2015. Estimates of disease burden and costeffectiveness. http://www.who.int/immunization/monitoring_surveillance/burden/estimates/en/. Accessed 9 April 2015.
8. Bezançon F, Griffon V. 1897. Pouvoir agglutinatif du sérum dans les infections expérimentales et humaines à pneumocoques. II C R Soc Biol 49:579.
9. Bezançon F, Griffon V. 1897. Pouvoir agglutinatif du sérum dans les infections expérimentales et humaines à pneumocoques. I C R Soc Biol 49:551.
10. Eyre JWH, Washbourn JW. 1899. Further experiments with Pane’s anti-pneumococcus serum. Br Med J 2:1247–1249.
11. Neufeld F, Haendel L. 1910. Weitere untersuchungen uber pneumokokken- heilsera. III. Mitteilung Arbeiten aus dem Kaiserlichen Gesundheitsamte 34:293–304.
12. Dochez AR, Gillespie LJ. 1913. A biologic classification of pneumococci by means of immunity reactions. JAMA 61:727–732. http://dx.doi.org/10.1001/jama.1913.04350100005003.
13. Lister FS. 1913. Specific serological reactions with pneumococci from different sources. South African Institute for Medical Research.
14. Cooper G, Rosenstein C, Walter A, Peizer L. 1932. The further separation of types among the pneumococci hitherto included in group IV and the development of therapeutic antisera for these types. J Exp Med 55:531–554. http://dx.doi.org/10.1084/jem.55.4.531.
15. Griffith F. 1928. The significance of pneumococcal types. J Hyg (Lond) 27:113–159. http://dx.doi.org/10.1017/S0022172400031879.
16. Pasteur L. 1881. Note sur la maladie nouvelle provoquée par la salive d’un enfant mort de la rage. Bull Acad Méd (Paris) 10:94–103.
17. Heidelberger M, Avery OT. 1923. The soluble specific substance of pneumococcus. J Exp Med 38:73–79. http://dx.doi.org/10.1084/jem.38.1.73.
18. Heidelberger M, Avery OT. 1924. The soluble specific substance of pneumococcus: second paper. J Exp Med 40:301–317. http://dx.doi.org/10.1084/jem.40.3.301.
19. Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS. 2010. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun 78:704–715. http://dx.doi.org/10.1128/IAI.00881-09.
20. Avery OT, Dubos R. 1931. The protective action of a specific enzyme against type III pneumococcus infection in mice. J Exp Med 54:73–89. http://dx.doi.org/10.1084/jem.54.1.73.
21. Reference deleted.
22. Vammen B. 1939. Serological variants of pneumococcus types 9 and 10. J Immunol 37:359–365.
23. Beckler E, Macleod P. 1934. The Neufeld method of pneumococcus type determination as carried out in a public health laboratory: a study of 760 typings. J Clin Invest 13:901–907. http://dx.doi.org/10.1172/JCI100634.
24. Lund E. 1960. Laboratory diagnosis of pneumococcus infections. Bull World Health Organ 23:5–13.
25. Eddy B. 1944. Cross reactions between the several pneumococcic types and their significance in the preparation of polyvalent antiserum. Public Health Rep 59:485–499. http://dx.doi.org/10.2307/4584847.
26. Kauffmann F, Lund E, Eddy BE. 1960. Proposal for a change in the nomenclature of Diplococcus pneumoniae and a comparison of the Danish and American type designations. Int Bull Bacteriol Nomencl Taxon 10:31–40.
27. Henrichsen J. 1995. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 33:2759–2762.
28. Calix JJ, Porambo RJ, Brady AM, Larson TR, Yother J, Abeygunwardana C, Nahm MH. 2012. Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem 287:27885–27894. http://dx.doi.org/10.1074/jbc.M112.380451.
29. Reeves RE, Goebel WF. 1941. Chemoimmunological studies on the soluble specific substance of pneumococcus. V. The structure of the type III polysaccharide. J Biol Chem 139:511–519.
30. Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, Donohoe K, Harris D, Murphy L, Quail MA, Samuel G, Skovsted IC, Kaltoft MS, Barrell B, Reeves PR, Parkhill J, Spratt BG. 2006. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet 2:e31. http://dx.doi.org/10.1371/journal.pgen.0020031.
31. Kamerling JP. 2000. Pneumococcal polysaccharides: a chemical view, p 81–114. In Tomasz A (ed), Streptococcus pneumoniae molecular biology & mechanisms of disease. Mary Ann Liebert, Inc., Larchmont, NY.
32. Jones C, Lemercinier X. 2005. Full NMR assignment and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 15B. Carbohydr Res 340:403–409. http://dx.doi.org/10.1016/j.carres.2004.12.009.
33. Abeygunawardana C, Williams TC, Sumner JS, Hennessey JP, Jr. 2000. Development and validation of an NMR-based identity assay for bacterial polysaccharides. Anal Biochem 279:226–240. http://dx.doi.org/10.1006/abio.1999.4470.
34. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH. 2007. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 45:1225–1233. http://dx.doi.org/10.1128/JCM.02199-06.
35. Cai P, Moran J, Pavliak V, Deng C, Khoury N, Marcq O, Ruppen ME. 2012.NMRstructural analysis of the capsular polysaccharide from Streptococcus pneumoniae serotype 6C. Carbohydr Res 351:98–107. http://dx.doi.org/10.1016/j.carres.2012.01.017.
36. Calix JJ, Nahm MH, Zartler ER. 2011. Elucidation of structural and antigenic properties of pneumococcal serotype 11A, 11B, 11C, and 11F polysaccharide capsules. J Bacteriol 193:5271–5278. http://dx.doi.org/10.1128/JB.05034-11.
37. Lin FL, Vinogradov E, Deng C, Zeller S, Phelan L, Green BA, Jansen KU, Pavliak V. 2014. Structure elucidation of capsular polysaccharides from Streptococcus pneumoniae serotype 33C, 33D, and revised structure of serotype 33B. Carbohydr Res 383:97–104. http://dx.doi.org/10.1016/j.carres.2013.11.006.
38. Synytsya A, Novak M. 2014. Structural analysis of glucans. Ann Transl Med 2:17. http://dx.doi.org/10.3978/j.issn.2305-5839.2014.02.07.
39. Widmalm G. 2013. A perspective on the primary and three-dimensional structures of carbohydrates. Carbohydr Res 378:123–132. http://dx.doi.org/10.1016/j.carres.2013.02.005.
40. Sorensen UBS, Henrichsen J, Chen H-C, Szu SC. 1990. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microb Pathog 8:325–334. http://dx.doi.org/10.1016/0882-4010(90)90091-4.
41. Vialle S, Sepulcri P, Dubayle J, Talaga P. 2005. The teichoic acid (C-polysaccharide) synthesized by Streptococcus pneumoniae serotype 5 has a specific structure. Carbohydr Res 340:91–96. http://dx.doi.org/10.1016/j.carres.2004.10.021.
42. Skovsted IC, Kerrn MB, Sonne-Hansen J, Sauer LE, Nielsen AK, Konradsen HB, Petersen BO, Nyberg NT, Duus JO. 2007. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays. Vaccine 25:6490–6500. http://dx.doi.org/10.1016/j.vaccine.2007.06.034.
43. Lewis AL, Nizet V, Varki A. 2004. Discovery and characterization of sialic acid O-acetylation in group B Streptococcus. Proc Natl Acad Sci U S A 101:11123–11128. http://dx.doi.org/10.1073/pnas.0403010101.
44. Rajam G, Carlone GM, Romero-Steiner S. 2007. Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C. Clin Vaccine Immunol 14:1223–1227. http://dx.doi.org/10.1128/CVI.00184-07.
45. McNeely TB, Staub JM, Rusk CM, Blum MJ, Donnelly JJ. 1998. Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques. Infect Immun 66:3705–3710.
46. Calix JJ, Saad JS, Brady AM, Nahm MH. 2012. Structural characterization of Streptococcus pneumoniae serotype 9A capsule polysaccharide reveals role of glycosyl 6-O-acetyltransferase wcjE in serotype 9V capsule biosynthesis and immunogenicity. J Biol Chem 287:13996–14003. http://dx.doi.org/10.1074/jbc.M112.346924.
47. Oliver MB, van der Linden MP, Kuntzel SA, Saad JS, Nahm MH. 2013. Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units. J Biol Chem 288: 25976–25985. http://dx.doi.org/10.1074/jbc.M113.480152.
48. Jennings HJ, Rosell K-G, Carlo DJ. 1980. Structural determination of the capsular polysaccharide of Streptococcus pneumoniae type-19 (19F). Can J Chem 58:1069–1074. http://dx.doi.org/10.1139/v80-167.
49. Ohno N, Yadomae T, Miyazaki T. 1980. The structure of the typespecific polysaccharide of pneumococcus type XIX. Carbohydr Res 80: 297–304. http://dx.doi.org/10.1016/S0008-6215(00)84868-5.
50. Katzenellenbogen E, Jennings HJ. 1983. Structural determination of the capsular polysaccharide of Streptococcus pneumoniae type 19A (57). Carbohydr Res 124:235–245. http://dx.doi.org/10.1016/0008-6215(83)88459-6.
51. Lee CJ, Fraser BA. 1980. The structures of the cross-reactive types 19 (19F) and 57 (19A) pneumococcal capsular polysaccharides. J Biol Chem 255:6847–6853.
52. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN. 2007. Capsule enhances pneumococcal colonization by limiting mucusmediated clearance. Infect Immun 75:83–90. http://dx.doi.org/10.1128/IAI.01475-06.
53. Brady AM, Calix JJ, Yu J, Geno KA, Cutter GR, Nahm MH. 2014. Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation. J Infect Dis 210:1155–1165. http://dx.doi.org/10.1093/infdis/jiu195.
54. Lindberg B, Lindqvist B, Lonngren J, Powell DA. 1980. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type1.CarbohydrRes 78:111–117.http://dx.doi.org/10.1016/S0008-6215(00)83664-2.
55. Tzianabos AO, Finberg RW, Wang Y, Chan M, Onderdonk AB, Jennings HJ, Kasper DL. 2000. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem 275:6733–6740. http://dx.doi.org/10.1074/jbc.275.10.6733.
56. Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL, Kasper DL. 1993. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 262:416–419. http://dx.doi.org/10.1126/science.8211161.
57. Safari D, Dekker HA, Joosten JA, Michalik D, de Souza AC, Adamo R, Lahmann M, Sundgren A, Oscarson S, Kamerling JP, Snippe H. 2008. Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14. Infect Immun 76:4615–4623. http://dx.doi.org/10.1128/IAI.00472-08.
58. Dawson MH. 1930. The transformation of pneumococcal types. II. The interconvertibility of type-specific S pneumococci. J Exp Med 51:123–147.
59. Effrussi-Taylor H. 1951. Genetic aspects of transformation of pneumococci. Cold Spring Harbor Symp Quant Biol 16:445–456. http://dx.doi.org/10.1101/SQB.1951.016.01.031.
60. Garcia E, Lopez R. 1997. Molecular biology of the capsular genes of Streptococcus pneumoniae. FEMS Microbiol Lett 149:1–10. http://dx.doi.org/10.1016/S0378-1097(97)00026-8.
61. Kolkman MA, van der Zeijst BA, Nuijten PJ. 1997. Functional analysis of glycosyltransferases encoded by the capsular polysaccharide biosynthesis locus of Streptococcus pneumoniae serotype 14. J Biol Chem 272: 19502–19508. http://dx.doi.org/10.1074/jbc.272.31.19502.
62. Kolkman MA, Wakarchuk W, Nuijten PJ, van der Zeijst BA. 1997. Capsular polysaccharide synthesis in Streptococcus pneumoniae serotype 14: molecular analysis of the complete cps locus and identification of genes encoding glycosyltransferases required for the biosynthesis of the tetrasaccharide subunit. Mol Microbiol 26:197–208. http://dx.doi.org/10.1046/j.1365-2958.1997.5791940.x.
63. Guidolin A, Morona JK, Morona R, Hansman D, Paton JC. 1994. Nucleotide sequence analysis of genes essential for capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 19F. Infect Immun 62:5384–5396.
64. Morona JK, Morona R, Paton JC. 1997. Characterization of the locus encoding the Streptococcus pneumoniae type 19F capsular polysaccharide biosynthetic pathway. Mol Microbiol 23:751–763. http://dx.doi.org/10.1046/j.1365-2958.1997.2551624.x.
65. Iannelli F, Pearce BJ, Pozzi G. 1999. The type 2 capsule locus of Streptococcus pneumoniae. J Bacteriol 181:2652–2654.
66. Dillard JP, Vandersea MW, Yother J. 1995. Characterization of the cassette containing genes for type 3 capsular polysaccharide biosynthesis in Streptococcus pneumoniae. J Exp Med 181:973–983. http://dx.doi.org/10.1084/jem.181.3.973.
67. Munoz R, Mollerach M, Lopez R, Garcia E. 1999. Characterization of the type 8 capsular gene cluster of Streptococcus pneumoniae. J Bacteriol 181:6214–6219.
68. Kolkman MA, van der Zeijst BA, Nuijten PJ. 1998. Diversity of capsular polysaccharide synthesis gene clusters in Streptococcus pneumoniae. J Biochem 123:937–945. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a022028.
69. Jiang SM, Wang L, Reeves PR. 2001. Molecular characterization of Streptococcus pneumoniae type 4, 6B, 8, and 18C capsular polysaccharide gene clusters. Infect Immun 69:1244–1255. http://dx.doi.org/10.1128/IAI.69.3.1244-1255.2001.
70. Morona JK, Morona R, Paton JC. 1999. Analysis of the 5= portion of the type 19A capsule locus identifies two classes of cpsC, cpsD, and cpsE genes in Streptococcus pneumoniae. J Bacteriol 181:3599–3605.
71. Varvio SL, Auranen K, Arjas E, Makela PH. 2009. Evolution of the capsular regulatory genes in Streptococcus pneumoniae. J Infect Dis 200: 1144–1151. http://dx.doi.org/10.1086/605651.
72. Llull D, Munoz R, Lopez R, Garcia E. 1999. A single gene (tts) located outside the cap locus directs the formation of Streptococcus pneumoniae type 37 capsular polysaccharide. Type 37 pneumococci are natural, genetically binary strains. J Exp Med 190:241–251.
73. Hardy GG, Caimano MJ, Yother J. 2000. Capsule biosynthesis and basic metabolism in Streptococcus pneumoniae are linked through the cellular phosphoglucomutase. J Bacteriol 182:1854–1863. http://dx.doi.org/10.1128/JB.182.7.1854-1863.2000.
74. Garcia E, Arrecubieta C, Munoz R, Mollerach M, Lopez R. 1997. A functional analysis of the Streptococcus pneumoniae genes involved in the synthesis of type 1 and type 3 capsular polysaccharides. Microb Drug Resist 3:73–88. http://dx.doi.org/10.1089/mdr.1997.3.73.
75. Yother J. 2011. Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu Rev Microbiol 65:563–581. http://dx.doi.org/10.1146/annurev.micro.62.081307.162944.
76. Llull D, Garcia E, Lopez R. 2001. Tts, a processive betaglucosyltransferase of Streptococcus pneumoniae, directs the synthesis of the branched type 37 capsular polysaccharide in pneumococcus and other gram-positive species. J Biol Chem 276:21053–21061. http://dx.doi.org/10.1074/jbc.M010287200.
77. Cartee RT, Forsee WT, Schutzbach JS, Yother J. 2000. Mechanism of type 3 capsular polysaccharide synthesis in Streptococcus pneumoniae. J Biol Chem 275:3907–3914. http://dx.doi.org/10.1074/jbc.275.6.3907.
78. Whitfield C. 2006. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 75:39–68. http://dx.doi.org/10.1146/annurev.biochem.75.103004.142545.
79. Xayarath B, Yother J. 2007. Mutations blocking side chain assembly, polymerization, or transport of a Wzy-dependent Streptococcus pneumoniae capsule are lethal in the absence of suppressor mutations and can affect polymer transfer to the cell wall. J Bacteriol 189:3369–3381. http: //dx.doi.org/10.1128/JB.01938-06.
80. James DB, Gupta K, Hauser JR, Yother J. 2013. Biochemical activities of Streptococcus pneumoniae serotype 2 capsular glycosyltransferases and significance of suppressor mutations affecting the initiating glycosyltransferase Cps2E. J Bacteriol 195:5469–5478. http://dx.doi.org/10.1128/JB.00715-13.
81. Kim JO, Weiser JN. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis 177:368–377. http://dx.doi.org/10.1086/514205.
82. Manso AS, Chai MH, Atack JM, Furi L, De Ste Croix M, Haigh R, Trappetti C, Ogunniyi AD, Shewell LK, Boitano M, Clark TA, Korlach J, Blades M, Mirkes E, Gorban AN, Paton JC, Jennings MP, Oggioni MR. 2014. A random six-phase switch regulates pneumococcal virulence via global epigenetic changes. Nat Commun 5:5055. http://dx.doi.org/10.1038/ncomms6055.
83. Weiser JN, Austrian R, Sreenivasan PK, Masure HR. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 62:2582–2589.
84. Cundell DR, Weiser JN, Shen J, Young A, Tuomanen EI. 1995. Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun 63:757–761.
85. Gilley RP, Orihuela CJ. 2014. Pneumococci in biofilms are noninvasive: implications on nasopharyngeal colonization. Front Cell Infect Microbiol 4:163. http://dx.doi.org/10.3389/fcimb.2014.00163.
86. Weiser JN, Bae D, Epino H, Gordon SB, Kapoor M, Zenewicz LA, Shchepetov M. 2001. Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae. Infect Immun 69: 5430–5439. http://dx.doi.org/10.1128/IAI.69.9.5430-5439.2001.
87. Geno KA, Hauser JR, Gupta K, Yother J. 2014. Streptococcus pneumoniae phosphotyrosine phosphatase CpsB and alterations in capsule production resulting from changes in oxygen availability. J Bacteriol 196: 1992–2003. http://dx.doi.org/10.1128/JB.01545-14.
88. Standish AJ, Salim AA, Zhang H, Capon RJ, Morona R. 2012. Chemical inhibition of bacterial protein tyrosine phosphatase suppresses capsule production. PLoS One 7:e36312. http://dx.doi.org/10.1371/journal.pone.0036312.
89. Bender MH, Cartee RT, Yother J. 2003. Positive correlation between tyrosine phosphorylation of CpsD and capsular polysaccharide production in Streptococcus pneumoniae. J Bacteriol 185:6057–6066. http://dx.doi.org/10.1128/JB.185.20.6057-6066.2003.
90. Morona JK, Paton JC, Miller DC, Morona R. 2000. Tyrosine phosphorylation of CpsD negatively regulates capsular polysaccharide biosynthesis in Streptococcus pneumoniae. Mol Microbiol 35:1431–1442. http://dx.doi.org/10.1046/j.1365-2958.2000.01808.x.
91. Ventura CL, Cartee RT, Forsee WT, Yother J. 2006. Control of capsular polysaccharide chain length by UDP-sugar substrate concentrations in Streptococcus pneumoniae. Mol Microbiol 61:723–733. http://dx.doi.org/10.1111/j.1365-2958.2006.05259.x.
92. Forsee WT, Cartee RT, Yother J. 2009. A kinetic model for chain length modulation of Streptococcus pneumoniae cellubiuronan capsular polysaccharide by nucleotide sugar donor concentrations. J Biol Chem 284: 11836–11844. http://dx.doi.org/10.1074/jbc.M900379200.
93. Carvalho SM, Farshchi Andisi V, Gradstedt H, Neef J, Kuipers OP, Neves AR, Bijlsma JJ. 2013. Pyruvate oxidase influences the sugar utilization pattern and capsule production in Streptococcus pneumoniae. PLoS One 8:e68277. http://dx.doi.org/10.1371/journal.pone.0068277.
94. Henriques MX, Rodrigues T, Carido M, Ferreira L, Filipe SR. 2011. Synthesis of capsular polysaccharide at the division septum of Streptococcus pneumoniae is dependent on a bacterial tyrosine kinase. Mol Microbiol 82:515–534. http://dx.doi.org/10.1111/j.1365-2958.2011.07828.x.
95. Nahm MH, Lin J, Finkelstein JA, Pelton SI. 2009. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis 199:320–325. http://dx.doi.org/10.1086/596064.
96. Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, Beall B, Shelly MA, Mahon BE, Nahm MH. 2008. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 198:1818–1822. http://dx.doi.org/10.1086/593339.
97. Burton RL, Nahm MH. 2012. Development of a fourfold multiplexed opsonophagocytosis assay for pneumococcal antibodies against additional serotypes and discovery of serological subtypes in Streptococcus pneumoniae serotype 20. Clin Vaccine Immunol 19:835–841. http://dx.doi.org/10.1128/CVI.00086-12.
98. Ko KS, Baek JY, Song JH. 2013. Capsular gene sequences and genotypes of “serotype 6E” Streptococcus pneumoniae isolates. J Clin Microbiol 51:3395–3399. http://dx.doi.org/10.1128/JCM.01645-13.
99. Mavroidi A, Godoy D, Aanensen DM, Robinson DA, Hollingshead SK, Spratt BG. 2004. Evolutionary genetics of the capsular locus of serogroup 6 pneumococci. J Bacteriol 186:8181–8192. http://dx.doi.org/10.1128/JB.186.24.8181-8192.2004.
100. Salter SJ, Hinds J, Gould KA, Lambertsen L, Hanage WP, Antonio M, Turner P, Hermans PW, Bootsma HJ, O’Brien KL, Bentley SD. 2012. Variation at the capsule locus, cps, of mistyped and non-typable Streptococcus pneumoniae isolates. Microbiology 158:1560–1569. http://dx.doi.org/10.1099/mic.0.056580-0.
101. Calix JJ, Nahm MH. 2010. A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. J Infect Dis 202:29–38. http://dx.doi.org/10.1086/653123.
102. Bratcher PE, Kim KH, Kang JH, Hong JY, Nahm MH. 2010. Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization. Microbiology 156: 555–560. http://dx.doi.org/10.1099/mic.0.034116-0.
103. Bratcher PE, Park IH, Hollingshead SK, Nahm MH. 2009. Production of a unique pneumococcal capsule serotype belonging to serogroup 6. Microbiology 155:576–583. http://dx.doi.org/10.1099/mic.0.024521-0.
104. van Selm S, van Cann LM, Kolkman MA, van der Zeijst BA, van Putten JP. 2003. Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect Immun 71:6192–6198. http://dx.doi.org/10.1128/IAI.71.11.6192-6198.2003.
105. Oliver MB, Jones C, Larson TR, Calix JJ, Zartler ER, Yother J, Nahm MH. 2013. Streptococcus pneumoniae serotype 11D has a bispecific glycosyltransferase and expresses two different capsular polysaccharide repeating units. J Biol Chem 288:21945–21954. http://dx.doi.org/10.1074/jbc.M113.488528.
106. Sheppard CL, Pichon B, George RC, Hall LM. 2010. Streptococcus pneumoniae isolates expressing a capsule with epitopes of both serotypes 6A and 6B. Clin Vaccine Immunol 17:1820–1822. http://dx.doi.org/10.1128/CVI.00335-10.
107. Sa-Leao R, Nunes S, Brito-Avo A, Frazao N, Simoes AS, Crisostomo MI, Paulo AC, Saldanha J, Santos-Sanches I, de Lencastre H. 2009. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect 15:1002–1007. http://dx.doi.org/10.1111/j.1469-0691.2009.02775.x.
108. van der Windt D, Bootsma HJ, Burghout P, van der Gaast-de Jongh CE, Hermans PW, van der Flier M. 2012. Nonencapsulated Streptococcus pneumoniae resists extracellular human neutrophil elastase- and cathepsin G-mediated killing. FEMS Immunol Med Microbiol 66:445– 448. http://dx.doi.org/10.1111/j.1574-695X.2012.01028.x.
109. Marsh R, Smith-Vaughan H, Hare KM, Binks M, Kong F, Warning J, Gilbert GL, Morris P, Leach AJ. 2010. The nonserotypeable pneumococcus: phenotypic dynamics in the era of anticapsular vaccines. J Clin Microbiol 48:831–835. http://dx.doi.org/10.1128/JCM.01701-09.
110. Hathaway LJ, Stutzmann Meier P, Battig P, Aebi S, Muhlemann K. 2004. A homologue of aliB is found in the capsule region of nonencapsulated Streptococcus pneumoniae. J Bacteriol 186:3721–3729. http://dx.doi.org/10.1128/JB.186.12.3721-3729.2004.
111. Park IH, Kim KH, Andrade AL, Briles DE, McDaniel LS, Nahm MH. 2012. Nontypeable pneumococci can be divided into multiple cps types, including one type expressing the novel gene pspK. mBio 3(3):e00035-00012. http://dx.doi.org/10.1128/mBio.00035-12.
112. Park IH, Geno KA, Sherwood LK, Nahm MH, Beall B. 2014. Population- based analysis of invasive nontypeable pneumococci reveals that most have defective capsule synthesis genes. PLoS One 9:e97825. http://dx.doi.org/10.1371/journal.pone.0097825.
113. Scott JR, Hinds J, Gould KA, Millar EV, Reid R, Santosham M, O’Brien KL, Hanage WP. 2012. Nontypeable pneumococcal isolates among Navajo and White Mountain Apache communities: are these really a cause of invasive disease? J Infect Dis 206:73–80. http://dx.doi.org/10.1093/infdis/jis307.
114. Melchiorre S, Camilli R, Pietrantoni A, Moschioni M, Berti F, Del Grosso M, Superti F, Barocchi MA, Pantosti A. 2012. Point mutations in wchA are responsible for the non-typability of two invasive Streptococcus pneumoniae isolates. Microbiology 158:338–344. http://dx.doi.org/10.1099/mic.0.054270-0.
115. Moscoso M, Garcia E, Lopez R. 2009. Pneumococcal biofilms. Int Microbiol 12:77–85. http://dx.doi.org/10.2436/20.1501.01.84.
116. Wartha F, Beiter K, Albiger B, Fernebro J, Zychlinsky A, Normark S, Henriques-Normark B. 2007. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol 9:1162–1171. http://dx.doi.org/10.1111/j.1462-5822.2006.00857.x.
117. Bootsma HJ, Egmont-Petersen M, Hermans PW. 2007. Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent Streptococcus pneumoniae: evidence for a distinct response to encapsulated strains. Infect Immun 75:5489–5499. http://dx.doi.org/10.1128/IAI.01823-06.
118. Kim JO, Romero-Steiner S, Sorensen UB, Blom J, Carvalho M, Barnard S, Carlone G, Weiser JN. 1999. Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae. Infect Immun 67:2327–2333.
119. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 60:111–116.
120. Janeway CA, Jr, Travers P, Walport M, Shlomchik MJ. 2001. Immunobiology: the immune system in health and disease, 5th ed. Garland Science, New York, NY.
121. Picard C, Puel A, Bustamante J, Ku CL, Casanova JL. 2003. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol 3:451–459. http://dx.doi.org/10.1097/00130832-200312000-00006.
122. Andreansky S, Liu H, Turner S, McCullers JA, Lang R, Rutschman R, Doherty PC, Murray PJ, Nienhuis AW, Strom TS. 2005. WASP mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG. Exp Hematol 33:443–451. http://dx.doi.org/10.1016/j.exphem.2004.12.006.
123. Robbins JB, Austrian R, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J, Makela PH, Broome CV, Facklam RR, Tiesjema RH, Parke JC, Jr. 1983. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the crossreactive types within groups. J Infect Dis 148:1136–1159. http://dx.doi.org/10.1093/infdis/148.6.1136.
124. Robbins JB, Schneerson R, Glode MP, Vann W, Schiffer MS, Liu TY, Parke JC, Jr, Huntley C. 1975. Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria. J Allergy Clin Immunol 56: 141–151. http://dx.doi.org/10.1016/0091-6749(75)90119-0.
125. Schneerson R, Robbins JB. 1975. Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed crossreacting Escherichia coli O75:K100:H5. N Engl J Med 292:1093–1096. http://dx.doi.org/10.1056/NEJM197505222922103.
126. Insel RA, Anderson PW. 1982. Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B. J Immunol 128:1267–1270.
127. Tarrand JJ, Scott MG, Takes PA, Nahm MH. 1989. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. Demonstration of three types of V regions and their association with H and L chain isotypes. J Immunol 142:2519–2526.
128. Lipsitch M, Whitney CG, Zell E, Kaijalainen T, Dagan R, Malley R. 2005. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med 2:e15. http://dx.doi.org/10.1371/journal.pmed.0020015.
129. Cobey S, Lipsitch M. 2012. Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335:1376–1380. http://dx.doi.org/10.1126/science.1215947.
130. Hyams C, Yuste J, Bax K, Camberlein E, Weiser JN, Brown JS. 2010. Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype. Infect Immun 78:716–725. http://dx.doi.org/10.1128/IAI.01056-09.
131. Quin LR, Moore QC, III, McDaniel LS. 2007. Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice. Infect Immun 75:2067–2070. http://dx.doi.org/10.1128/IAI.01727-06.
132. Yuste J, Khandavilli S, Ansari N, Muttardi K, Ismail L, Hyams C, Weiser J, Mitchell T, Brown JS. 2010. The effects of PspC on complement- mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype. Infect Immun 78:283–292. http://dx.doi.org/10.1128/IAI.00541-09.
133. Hyams C, Trzcinski K, Camberlein E, Weinberger DM, Chimalapati S, Noursadeghi M, Lipsitch M, Brown JS. 2013. Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonisation with C3b/iC3b. Infect Immun 81:354–363. http://dx.doi.org/10.1128/IAI.00862-12.
134. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. 2000. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30:100–121. http://dx.doi.org/10.1086/313608.
135. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. 2000. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 30:122–140. http://dx.doi.org/10.1086/313609.
136. Hausdorff WP, Feikin DR, Klugman KP. 2005. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5:83–93. http://dx.doi.org/10.1016/S1473-3099(05)01280-6.
137. Melin M, Trzcinski K, Meri S, Kayhty H, Vakevainen M. 2010. The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect Immun 78:5262–5270. http://dx.doi.org/10.1128/IAI.00740-10.
138. Kjaer TR, Hansen AG, Sorensen UB, Holm AT, Sorensen GL, Jensenius JC, Thiel S. 2013. M-ficolin binds selectively to the capsular polysaccharides of Streptococcus pneumoniae serotypes 19B and 19C and of a Streptococcus mitis strain. Infect Immun 81:452–459. http://dx.doi.org/10.1128/IAI.01148-12.
139. Krarup A, Sorensen UB, Matsushita M, Jensenius JC, Thiel S. 2005. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 73:1052–1060. http://dx.doi.org/10.1128/IAI.73.2.1052-1060.2005.
140. Bennett LG, Bishop CT. 1977. Structure of the type XXVII Streptococcus pneumoniae (pneumococcal) capsular polysaccharide. Can J Chem 55: 8–16. http://dx.doi.org/10.1139/v77-002.
141. Bennett LG, Bishop CT. 1977. The pyruvate ketal as a stereospecific immunodeterminant in the type XXVII Streptococcus pneumoniae (pneumococcal) capsular polysaccharide. Immunochemistry 14:693–696. http://dx.doi.org/10.1016/0019-2791(77)90143-4.
142. Edwards KM, Gewurz H, Lint TF, Mold C. 1982. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae. J Immunol 128:2493–2496.
143. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR. 2010. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201:32–41. http://dx.doi.org/10.1086/648593.
144. Spellerberg B, Cundell DR, Sandros J, Pearce BJ, Idanpaan-Heikkila I, Rosenow C, Masure HR. 1996. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol Microbiol 19:803–813. http://dx.doi.org/10.1046/j.1365-2958.1996.425954.x.
145. Syk A, Norman M, Fernebro J, Gallotta M, Farmand S, Sandgren A, Normark S, Henriques-Normark B. 2014. Emergence of hypervirulent mutants resistant to early clearance during systemic serotype 1 pneumococcal infection in mice and humans. J Infect Dis 210:4–13. http://dx.doi.org/10.1093/infdis/jiu038.
146. Calix JJ, Dagan R, Pelton SI, Porat N, Nahm MH. 2012. Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution. Clin Infect Dis 54:794–799. http://dx.doi.org/10.1093/cid/cir953.
147. Calix JJ, Oliver MB, Sherwood LK, Beall BW, Hollingshead SK, Nahm MH. 2011. Streptococcus pneumoniae serotype 9A isolates contain diverse mutations to wcjE that result in variable expression of serotype 9Vspecific epitope. J Infect Dis 204:1585–1595. http://dx.doi.org/10.1093/infdis/jir593.
148. Austrian R. 1986. Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 18(Suppl A):35–45. http://dx.doi.org/10.1093/jac/18.1.35.
149. Buck JM, Lexau C, Shapiro M, Glennen A, Boxrud DJ, Koziol B, Whitney CG, Beall B, Danila R, Lynfield R. 2006. A community outbreak of conjunctivitis caused by nontypeable Streptococcus pneumoniae in Minnesota. Pediatr Infect Dis J 25:906–911. http://dx.doi.org/10.1097/01.inf.0000238143.96607.ec.
150. Martin M, Turco JH, Zegans ME, Facklam RR, Sodha S, Elliott JA, Pryor JH, Beall B, Erdman DD, Baumgartner YY, Sanchez PA, Schwartzman JD, Montero J, Schuchat A, Whitney CG. 2003. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med 348:1112–1121. http://dx.doi.org/10.1056/NEJMoa022521.
151. Keller LE, Jones CV, Thornton JA, Sanders ME, Swiatlo E, Nahm MH, Park IH, McDaniel LS. 2013. PspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonization. Infect Immun 81:173–181. http://dx.doi.org/10.1128/IAI.00755-12.
152. Scott JA, Hall AJ, Dagan R, Dixon JM, Eykyn SJ, Fenoll A, Hortal M, Jette LP, Jorgensen JH, Lamothe F, Latorre C, Macfarlane JT, Shlaes DM, Smart LE, Taunay A. 1996. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis 22:973–981. http://dx.doi.org/10.1093/clinids/22.6.973.
153. Lee S, Bae S, Lee KJ, Yu JY, Kang Y. 2013. Changes in serotype prevalence and antimicrobial resistance among invasive Streptococcus pneumoniae isolates in Korea, 1996-2008. J Med Microbiol 62:1204–1210. http://dx.doi.org/10.1099/jmm.0.058164-0.
154. Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, Lambertsen L, Krogfelt KA, Konradsen HB, Benfield TL. 2009. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 6:e1000081. http://dx.doi.org/10.1371/journal.pmed.1000081.
155. Grabenstein JD, Musey LK. 2014. Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. Vaccine 32:2399–2405. http://dx.doi.org/10.1016/j.vaccine.2014.02.096.
156. Grabenstein JD, Klugman KP. 2012. A century of pneumococcal vaccination research in humans. Clin Microbiol Infect 18(Suppl 5):S15–S24. http://dx.doi.org/10.1111/j.1469-0691.2012.03943.x.
157. Nuorti JP, Whitney CG. 2010. Prevention of pneumococcal disease among infants and children—use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine— recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59:1–18.
158. Austrian R. 1977. Session II. Immunity to encapsulated bacteria prevention of pneumococcal infection by immunization with capsular polysaccharides of streptococcus pneumoniae: current status of polyvalent vaccines. J Infect Dis 136:S38–S42.
159. Makela PH, Butler JC. 2008. History of pneumococcal immunization, p 19–29. In Siber GR, Klugman KP, Makela PH (ed), Pneumococcal vaccines. ASM Press, Washington, DC.
160. Sorensen UBS, Henrichsen J. 1984. C-polysaccharide in a pneumococcal vaccine. Acta Pathol Microbiol Immunol Scand C 92:351–356.
161. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE. 1990. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 161:728–735. http://dx.doi.org/10.1093/infdis/161.4.728.
162. Song JY, Moseley MA, Burton RL, Nahm MH. 2013. Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother 19: 412–425. http://dx.doi.org/10.1007/s10156-013-0601-1.
163. Moberley S, Holden J, Tatham DP, Andrews RM. 2013. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 1:CD000422. http://dx.doi.org/10.1002/14651858.CD000422.pub2.
164. Andrews NJ, Waight PA, George RC, Slack MP, Miller E. 2012. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. Vaccine 30:6802–6808. http://dx.doi.org/10.1016/j.vaccine.2012.09.019.
165. Rosen C, Christensen P, Hovelius B, Prellner K. 1984. A longitudinal study of the nasopharyngeal carriage of pneumococci as related to pneumococcal vaccination in children attending day-care centres. Acta Otolaryngol 98:524–532. http://dx.doi.org/10.3109/00016488409107593.
166. Herva E, Luotonen J, Timonen M, Sibakov M, Karma P, Makela PH. 1980. The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae. Scand J Infect Dis 12:97–100. http://dx.doi.org/10.3109/inf.1980.12.issue-2.04.
167. Douglas RM, Hansman D, Miles HB, Paton JC. 1986. Pneumococcal carriage and type-specific antibody. Failure of a 14-valent vaccine to reduce carriage in healthy children. Am J Dis Child 140:1183–1185.
168. Black S, Eskola J, Whitney C, Shinefield H. 2008. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines, p 531– 568. In Plotkin SA, Orenstein WA, Offit PA (ed), Vaccines, 5th ed. WB Saunders Company, Philadelphia, PA.
169. O’Brien KL, Santosham M. 2004. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. Am J Epidemiol 159:634–644. http://dx.doi.org/10.1093/aje/kwh082.
170. Dagan R, Givon-Lavi N, Greenberg D, Fritzell B, Siegrist CA. 2010. Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy. J Infect Dis 201:1570–1579. http://dx.doi.org/10.1086/652006.
171. O’Brien KL, Hochman M, Goldblatt D. 2007. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis 7:597–606. http://dx.doi.org/10.1016/S1473-3099(07)70210-4.
172. Clutterbuck EA, Lazarus R, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, Pollard AJ. 2012. Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J Infect Dis 205:1408–1416. http://dx.doi.org/10.1093/infdis/jis212.
173. Black S, Shinefield HR, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19:187–195.
174. Centers for Disease Control and Prevention. 2012. Licensure of 13- valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR Morb Mortal Wkly Rep 61:394–395.
175. Poolman JT, Peeters CC, van den Dobbelsteen GP. 2013. The history of pneumococcal conjugate vaccine development: dose selection. Expert Rev Vaccines 12:1379–1394. http://dx.doi.org/10.1586/14760584.2013.852475.
176. Dagan R, Poolman J, Siegrist CA. 2010. Glycoconjugate vaccines and immune interference: a review. Vaccine 28:5513–5523. http://dx.doi.org/10.1016/j.vaccine.2010.06.026.
177. Poolman J, Frasch C, Nurkka A, Kayhty H, Biemans R, Schuerman L. 2011. Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines. Clin Vaccine Immunol 18:327–336. http://dx.doi.org/10.1128/CVI.00402-10.
178. Obaro SK. 2002. The new pneumococcal vaccine. Clin Microbiol Infect 8:623–633. http://dx.doi.org/10.1046/j.1469-0691.2002.00424.x.
179. Feldman C, Anderson R. 2014. Current and new generation pneumococcal vaccines. J Infect 69:309–325. http://dx.doi.org/10.1016/j.jinf.2014.06.006.
180. European Medicines Agency. 2015. Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed):summaryof product characteristics. http: //www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product _Information/human/000973/WC500054346.pdf. Accessed 1 April 2015.
181. Centers for Disease Control and Prevention. 2010. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children—Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 59:258–261.
182. Centers for Disease Control and Prevention. 2012. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 61:816–819.
183. Centers for Disease Control and Prevention. 2013. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6–18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 62:521–524.
184. Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T, Centers for Disease Control and Prevention. 2014. Use of 13-valent pneumococcal conjugate vaccine and 23- valent pneumococcal polysaccharide vaccine among adults aged _65 years: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 63:822–825.
185. Lee H, Nahm MH, Burton R, Kim KH. 2009. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine- related serotypes 6A and 19A. Clin Vaccine Immunol 16:376–381. http://dx.doi.org/10.1128/CVI.00344-08.
186. Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, Santos JB, de Moraes JC, Brazilian Pneumococcal Conjugate Vaccine Effectiveness Study Group. 2014. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched casecontrol study. Lancet Respir Med 2:464–471. http://dx.doi.org/10.1016/S2213-2600(14)70060-8.
187. Yu X, Gray B, Chang S, Ward JI, Edwards KM, Nahm MH. 1999. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J Infect Dis 180:1569–1576. http://dx.doi.org/10.1086/315096.
188. Juergens C, Patterson S, Trammel J, Greenberg D, Givon-Lavi N, Cooper D, Gurtman A, Gruber WC, Scott DA, Dagan R. 2014. Post hoc analysis of a randomized double-blind trial of the correlation of func- tional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization. Clin Vaccine Immunol 21:1277–1281. http://dx.doi.org/10.1128/CVI.00172-14.
189. Andrews NJ, Waight PA, Burbidge P, Pearce E, Roalfe L, Zancolli M, Slack M, Ladhani SN, Miller E, Goldblatt D. 2014. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis 14:839–846. http://dx.doi.org/10.1016/S1473-3099(14)70822-9.
190. Harboe ZB, Dalby T, Weinberger DM, Benfield T, Molbak K, Slotved HC, Suppli CH, Konradsen HB, Valentiner-Branth P. 2014. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis 59:1066–1073. http://dx.doi.org/10.1093/cid/ciu524.
191. Lucero MG, Dulalia VE, Nillos LT, Williams G, Parreno RA, Nohynek H, Riley ID, Makela H. 2009. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst Rev CD004977. http://dx.doi.org/10.1002/14651858.CD004977.pub2.
192. Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, van Werkhoven CH, van Deursen AM, Sanders EA, Verheij TJ, Patton M, McDonough A, Moradoghli-Haftvani A, Smith H, Mellelieu T, Pride MW, Crowther G, Schmoele-Thoma B, Scott DA, Jansen KU, Lobatto R, Oosterman B, Visser N, Caspers E, Smorenburg A, Emini EA, Gruber WC, Grobbee DE. 2015. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 372:1114–1125. http://dx.doi.org/10.1056/NEJMoa1408544.
193. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. 2003. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22:10–16. http://dx.doi.org/10.1097/00006454-200301000-00006.
194. Centers for Disease Control and Prevention. 2005. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease– United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54:893–897.
195. Park SY, Moore MR, Bruden DL, Hyde TB, Reasonover AL, Harker- Jones M, Rudolph KM, Hurlburt DA, Parks DJ, Parkinson AJ, Schuchat A, Hennessy TW. 2008. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J 27:335–340. http://dx.doi.org/10.1097/INF.0b013e318161434d.
196. Link-Gelles R, Taylor T, Moore MR, Active Bacterial Core Surveillance T. 2013. Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020. Vaccine 31:2572–2577. http://dx.doi.org/10.1016/j.vaccine.2013.03.049.
197. Song JY, Nahm MH, Moseley MA. 2013. Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean Med Sci 28:4–15. http://dx.doi.org/10.3346/jkms.2013.28.1.4.
198. Fedson DS, Nicolas-Spony L, Klemets P, van der Linden M, Marques A, Salleras L, Samson SI. 2011. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert Rev Vaccines 10: 1143–1167. http://dx.doi.org/10.1586/erv.11.99.
199. Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, Miller L, Scherzinger K, Thomas A, Farley MM, Zell ER, Taylor TH, Jr, Pondo T, Rodgers L, McGee L, Beall B, Jorgensen JH, Whitney CG. 2015. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis 15:301–309. http://dx.doi.org/10.1016/S1473-3099(14)71081-3.
200. Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, Wang H, Lu M, So TM, Hsueh PR, Yasin RM, Carlos CC, Pham HV, Lalitha MK, Shimono N, Perera J, Shibl AM, Baek JY, Kang CI, Ko KS, Peck KR, ANSORP Study Group. 2012. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 56:1418–1426. http://dx.doi.org/10.1128/AAC.05658-11.
201. Ritchie ND, Mitchell TJ, Evans TJ. 2012. What is different about serotype 1 pneumococci? Future Microbiol 7:33–46. http://dx.doi.org/10.2217/fmb.11.146.
202. Jauneikaite E, Tocheva AS, Jefferies JM, Gladstone RA, Faust SN, Christodoulides M, Hibberd ML, Clarke SC. 2015. Current methods for capsular typing of Streptococcus pneumoniae. J Microbiol Methods 113:41–49. http://dx.doi.org/10.1016/j.mimet.2015.03.006.
203. Pimenta FC, Roundtree A, Soysal A, Bakir M, du Plessis M, Wolter N, von Gottberg A, McGee L, Carvalho MDG, Beall B. 2013. Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden. J Clin Microbiol 51:647–652. http://dx.doi.org/10.1128/JCM.02927-12.
204. Konradsen HB. 2005. Validation of serotyping of Streptococcus pneumoniae in Europe. Vaccine 23:1368–1373. http://dx.doi.org/10.1016/j.vaccine.2004.09.011.
205. Kuch A, Golebiewska A, Wasko I, Ronkiewicz P, Markowska M, Hryniewicz W, Skoczynska A. 2014. Usefulness of Pneumotest-Latex for direct serotyping of Streptococcus pneumoniae isolates in clinical samples. J Clin Microbiol 52:2647–2649. http://dx.doi.org/10.1128/JCM.00451-14.
206. Sorensen UBS. 1993. Typing of pneumococci by using 12 pooled antisera. J Clin Microbiol 31:2097–2100.
207. Fenoll A, Jado A, Vicioso D, Casal J. 1997. Dot blot assay for the serotyping of pneumococci. J Clin Microbiol 35:764–766.
208. Lankinen KS, Rintamaki S, Syrjanen R, Kilpi T, Ruutu P, Leinonen M. 2004. Type-specific enzyme immunoassay for detection of pneumococcal capsular polysaccharide antigens in nasopharyngeal specimens. J Microbiol Methods 56:193–199. http://dx.doi.org/10.1016/j.mimet.2003.10.021.
209. Lafong AC, Crothers E. 1988. Simple latex agglutination method for typing pneumococci. J Clin Pathol 41:230–231. http://dx.doi.org/10.1136/jcp.41.2.230.
210. Slotved HC, Kaltoft M, Skovsted IC, Kerrn MB, Espersen F. 2004. Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex). J Clin Microbiol 42:2518–2522. http://dx.doi.org/10.1128/JCM.42.6.2518-2522.2004.
211. Park S, Parameswar AR, Demchenko AV, Nahm MH. 2009. Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups. Infect Immun 77:3374–3379. http://dx.doi.org/10.1128/IAI.00319-09.
212. Yu J, Lin J, Kim KH, Benjamin WH, Jr, Nahm MH. 2011. Development of an automated and multiplexed serotyping assay for Streptococcus pneumoniae. Clin Vaccine Immunol 18:1900–1907. http://dx.doi.org/10.1128/CVI.05312-11.
213. Sahu RK, Mordechai S, Pesakhov S, Dagan R, Porat N. 2006. Use of FTIR spectroscopy to distinguish between capsular types and capsular quantities in Streptococcus pneumoniae. Biopolymers 83:434–442. http://dx.doi.org/10.1002/bip.20576.
214. Lartigue MF, Hery-Arnaud G, Haguenoer E, Domelier AS, Schmit PO, vanderMee-Marquet N, Lanotte P, Mereghetti L, Kostrzewa M, Quentin R. 2009. Identification of Streptococcus agalactiae isolates from various phylogenetic lineages by matrix-assisted laser desorption ionization- time of flight mass spectrometry. J Clin Microbiol 47:2284–2287. http://dx.doi.org/10.1128/JCM.00175-09.
215. Camilli R, Spencer BL, Moschioni M, Pinto V, Berti F, Nahm MH, Pantosti A. 2014. Identification of Streptococcus pneumoniae serotype 11E, serovariant 11Av and mixed populations by high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and flow cytometric serotyping assay (FCSA). PLoS One 9:e100722. http://dx.doi.org/10.1371/journal.pone.0100722.
216. Lawrence ER, Arias CA, Duke B, Beste D, Broughton K, Efstratiou A, George RC, Hall LM. 2000. Evaluation of serotype prediction by cpsAcpsB gene polymorphism in Streptococcus pneumoniae. J Clin Microbiol 38:1319–1323.
217. Batt SL, Charalambous BM, McHugh TD, Martin S, Gillespie SH. 2005. Novel PCR-restriction fragment length polymorphism method for determining serotypes or serogroups of Streptococcus pneumoniae isolates. J Clin Microbiol 43:2656–2661. http://dx.doi.org/10.1128/JCM.43.6.2656-2661.2005.
218. Lawrence ER, Griffiths DB, Martin SA, George RC, Hall LM. 2003. Evaluation of semiautomated multiplex PCR assay for determination of Streptococcus pneumoniae serotypes and serogroups. J Clin Microbiol 41: 601–607. http://dx.doi.org/10.1128/JCM.41.2.601-607.2003.
219. Brito DA, Ramirez M, de Lencastre H. 2003. Serotyping Streptococcuspneumoniae by multiplex PCR. J Clin Microbiol 41:2378–2384. http://dx.doi.org/10.1128/JCM.41.6.2378-2384.2003.
220. Kong F, Gilbert GL. 2003. Using cpsA-cpsB sequence polymorphisms and serotype-/group-specific PCR to predict 51 Streptococcus pneumoniae capsular serotypes. J Med Microbiol 52:1047–1058. http://dx.doi.org/10.1099/jmm.0.05277-0.
221. Kong F, Wang W, Tao J, Wang L, Wang Q, Sabananthan A, Gilbert GL. 2005. A molecular-capsular-type prediction system for 90 Streptococcus pneumoniae serotypes using partial cpsA-cpsB sequencing and wzy- or wzx-specific PCR. J Med Microbiol 54:351–356. http://dx.doi.org/10.1099/jmm.0.45924-0.
222. Pai R, Gertz RE, Beall B. 2006. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 44:124–131. http://dx.doi.org/10.1128/JCM.44.1.124-131.2006.
223. Azzari C, Moriondo M, Indolfi G, Massai C, Becciolini L, de Martino M, Resti M. 2008. Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J Med Microbiol 57:1205–1212. http://dx.doi.org/10.1099/jmm.0.2008/000935-0.
224. Dias CA, Teixeira LM, Carvalho MDG, Beall B. 2007. Sequential multiplex PCR for determining capsular serotypes of pneumococci recovered from Brazilian children. J Med Microbiol 56:1185–1188. http://dx.doi.org/10.1099/jmm.0.47347-0.
225. Morais L, Carvalho MDG, Roca A, Flannery B, Mandomando I, Soriano-Gabarro M, Sigauque B, Alonso P, Beall B. 2007. Sequential multiplex PCR for identifying pneumococcal capsular serotypes from South-Saharan African clinical isolates. J Med Microbiol 56:1181–1184. http://dx.doi.org/10.1099/jmm.0.47346-0.
226. Njanpop Lafourcade BM, Sanou O, van der Linden M, Levina N, Karanfil M, Yaro S, Tamekloe TA, Mueller JE. 2010. Serotyping pneumococcal meningitis cases in the African meningitis belt by use of multiplex PCR with cerebrospinal fluid. J Clin Microbiol 48:612–614. http://dx.doi.org/10.1128/JCM.01402-09.
227. Saha SK, Darmstadt GL, Baqui AH, Hossain B, Islam M, Foster D, Al-Emran H, Naheed A, Arifeen SE, Luby SP, Santosham M, Crook D. 2008. Identification of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: implication for surveillance and vaccine design. PLoS One 3:e3576. http://dx.doi.org/10.1371/journal.pone.0003576.
228. da Gloria Carvalho M, Pimenta FC, Jackson D, Roundtree A, Ahmad Y, Millar EV, O’Brien KL, Whitney CG, Cohen AL, Beall BW. 2010. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol 48:1611–1618. http://dx.doi.org/10.1128/JCM.02243-09.
229. Pimenta FC, Carvalho MDG, Gertz RE, Jr, Bastos-Rocha CG, Oliveira LS, Lacerda Pigosso L, Lima JA, Marquez Franco C, Andrade AL, Beall BW. 2011. Serotype and genotype distributions of pneumococcal carriage isolates recovered from Brazilian children attending day-care centres. J Med Microbiol 60:1455–1459. http://dx.doi.org/10.1099/jmm.0.031450-0.
230. Massire C, Gertz RE, Jr, Svoboda P, Levert K, Reed MS, Pohl J, Kreft R, Li F, White N, Ranken R, Blyn LB, Ecker DJ, Sampath R, Beall B. 2012. Concurrent serotyping and genotyping of pneumococci by use of PCR and electrospray ionization mass spectrometry. J Clin Microbiol 50:2018–2025. http://dx.doi.org/10.1128/JCM.06735-11.
231. Tokarz R, Briese T, Morris G, Ideh R, Chimah O, Ebruke B, Desai A, Haq S, Sameroff S, Howie SR, Lipkin WI. 2013. Serotype analysis of Streptococcus pneumoniae in lung and nasopharyngeal aspirates from children in the Gambia by MassTag PCR. J Clin Microbiol 51:995–997. http://dx.doi.org/10.1128/JCM.02974-12.
232. Azzari C, Moriondo M, Indolfi G, Cortimiglia M, Canessa C, Becciolini L, Lippi F, de Martino M, Resti M. 2010. Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLoS One 5:e9282. http://dx.doi.org/10.1371/journal.pone.0009282.
233. Marchese A, Esposito S, Coppo E, Rossi GA, Tozzi A, Romano M, Da Dalt L, Schito GC, Principi N. 2011. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children _ 5 years of age with community-acquired pneumonia. Microb Drug Resist 17:419–424. http://dx.doi.org/10.1089/mdr.2011.0031.
234. Tarrago D, Fenoll A, Sanchez-Tatay D, Arroyo LA, Munoz-Almagro C, Esteva C, Hausdorff WP, Casal J, Obando I. 2008. Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect 14:828–834. http://dx.doi.org/10.1111/j.1469-0691.2008.02028.x.
235. Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K. 2011. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 30:289–294. http://dx.doi.org/10.1097/INF.0b013e3182002d14.
236. Magomani V, Wolter N, Tempia S, du Plessis M, de Gouveia L, von Gottberg A. 2014. Challenges of using molecular serotyping for surveillance of pneumococcal disease. J Clin Microbiol 52:3271–3276. http://dx.doi.org/10.1128/JCM.01061-14.
237. Pai R, Limor J, Beall B. 2005. Use of pyrosequencing to differentiate Streptococcus pneumoniae serotypes 6A and 6B. J Clin Microbiol 43: 4820–4822. http://dx.doi.org/10.1128/JCM.43.9.4820-4822.2005.
238. Park IH, Park S, Hollingshead SK, Nahm MH. 2007. Genetic basis for the new pneumococcal serotype, 6C. Infect Immun 75:4482–4489. http://dx.doi.org/10.1128/IAI.00510-07.
239. Jacobs MR, Bajaksouzian S, Bonomo RA, Good CE, Windau AR, Hujer AM, Massire C, Melton R, Blyn LB, Ecker DJ, Sampath R. 2009. Occurrence, distribution, and origins of Streptococcus pneumoniae serotype 6C, a recently recognized serotype. J Clin Microbiol 47:64–72. http://dx.doi.org/10.1128/JCM.01524-08.
240. Jin P, Xiao M, Kong F, Oftadeh S, Zhou F, Liu C, Gilbert GL. 2009. Simple, accurate, serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B, and 6C. J Clin Microbiol 47:2470–2474. http://dx.doi.org/10.1128/JCM.00484-09.
241. Jin P, Kong F, Xiao M, Oftadeh S, Zhou F, Liu C, Russell F, Gilbert GL. 2009. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis 200: 1375–1380. http://dx.doi.org/10.1086/606118.
242. Kong F, Brown M, Sabananthan A, Zeng X, Gilbert GL. 2006. Multiplex PCR-based reverse line blot hybridization assay to identify 23 Streptococcus pneumoniae polysaccharide vaccine serotypes. J Clin Microbiol 44:1887–1891. http://dx.doi.org/10.1128/JCM.44.5.1887-1891.2006.
243. Zhou F, Kong F, Tong Z, Gilbert GL. 2007. Identification of lesscommon Streptococcus pneumoniae serotypes by a multiplex PCR-based reverse line blot hybridization assay. J Clin Microbiol 45:3411–3415. http://dx.doi.org/10.1128/JCM.01076-07.
244. Strachan RE, Cornelius A, Gilbert GL, Gulliver T, Martin A, Mc- Donald T, Nixon G, Roseby R, Ranganathan S, Selvadurai H, Smith G, Soto-Martinez M, Suresh S, Teoh L, Thapa K, Wainwright CE, Jaffe A. 2012. Pleural fluid nucleic acid testing enhances pneumococcal surveillance in children. Respirology 17:114–119. http://dx.doi.org/10.1111/j.1440-1843.2011.02035.x.
245. Lochindarat S, Teeratakulpisarn J, Warachit B, Chanta C, Thapa K, Gilbert GL, Wangroongsarb Y, Pircon JY, Van Dyke MK, Liu Y, Hausdorff WP. 2014. Bacterial etiology of empyema thoracis and parapneumonic pleural effusion in Thai children aged less than 16 years. Southeast Asian J Trop Med Public Health 45:442–454.
246. Wang Q, Wang M, Kong F, Gilbert GL, Cao B, Wang L, Feng L. 2007. Development of a DNA microarray to identify the Streptococcus pneumoniae serotypes contained in the 23-valent pneumococcal polysaccharide vaccine and closely related serotypes. J Microbiol Methods 68:128–136. http://dx.doi.org/10.1016/j.mimet.2006.07.001.
247. Reference deleted.
248. Newton R, Hinds J, Wernisch L. 2011. Empirical Bayesian models for analysing molecular serotyping microarrays. BMCBioinformatics 12:88. http://dx.doi.org/10.1186/1471-2105-12-88.
249. Brugger SD, Frey P, Aebi S, Hinds J, Muhlemann K. 2010. Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine. PLoS One 5:e11638. http://dx.doi.org/10.1371/journal.pone.0011638.
250. Turner P, Hinds J, Turner C, Jankhot A, Gould K, Bentley SD, Nosten F, Goldblatt D. 2011. Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray. J Clin Microbiol 49:1784–1789. http://dx.doi.org/10.1128/JCM.00157-11.
251. Valente C, Hinds J, Pinto F, Brugger SD, Gould K, Muhlemann K, de Lencastre H, Sa-Leao R. 2012. Decrease in pneumococcal co- colonization following vaccination with the seven-valent pneumococcal conjugate vaccine. PLoS One 7:e30235. http://dx.doi.org/10.1371/journal.pone.0030235.
252. Scott JR, Hanage WP, Lipsitch M, Millar EV, Moulton LH, Hinds J, Reid R, Santosham M, O’Brien KL. 2012. Pneumococcal sequence type replacement among American Indian children: a comparison of pre- and routine-PCV7 eras. Vaccine 30:2376–2381. http://dx.doi.org/10.1016/j.vaccine.2011.11.004.
253. Tomita Y, Okamoto A, Yamada K, Yagi T, Hasegawa Y, Ohta M. 2011. A new microarray system to detect Streptococcus pneumoniae serotypes. J Biomed Biotechnol 2011:352736. http://dx.doi.org/10.1155/2011/352736.
254. Raymond F, Boucher N, Allary R, Robitaille L, Lefebvre B, Tremblay C, Corbeil J, Gervaix A. 2013. Serotyping of Streptococcus pneumoniae based on capsular genes polymorphisms. PLoS One 8:e76197. http://dx.doi.org/10.1371/journal.pone.0076197.
255. Strachan RE, Cornelius A, Gilbert GL, Gulliver T, Martin A, Mc- Donald T, Nixon GM, Roseby R, Ranganathan S, Selvadurai H, Smith G, Soto-Martinez M, Suresh S, Teoh L, Thapa K, Wainwright CE, Jaffe A, Australian Research Network in Empyema. 2011. Bacterial causes of empyema in children, Australia, 2007-2009. Emerg Infect Dis 17:1839–1845. http://dx.doi.org/10.3201/eid1710.101825.
256. Anthony L, Meehan A, Amos B, Mtove G, Mjema J, Malahiyo R, Yin JK, Oftadeh S, Gilbert GL, Shingadia D, Reyburn H, Deen J, Richmond PC, Booy R. 2012. Nasopharyngeal carriage of Streptococcus pneumoniae: prevalence and risk factors in HIV-positive children in Tanzania. Int J Infect Dis 16:e753–757. http://dx.doi.org/10.1016/j.ijid.2012.05.1037.
257. Wyres KL, Lambertsen LM, Croucher NJ, McGee L, von Gottberg A, Linares J, Jacobs MR, Kristinsson KG, Beall BW, Klugman KP, Parkhill J, Hakenbeck R, Bentley SD, Brueggemann AB. 2013. Pneumococcal capsular switching: a historical perspective. J Infect Dis 207:439–449. http://dx.doi.org/10.1093/infdis/jis703.
258. Leung MH, Bryson K, Freystatter K, Pichon B, Edwards G, Charalambous BM, Gillespie SH. 2012. Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy. J Clin Microbiol 50: 2419–2427. http://dx.doi.org/10.1128/JCM.06384-11.
259. Liyanapathirana V, Ang I, Tsang D, Fung K, Ng TK, Zhou H, Ip M. 2014. Application of a target enrichment-based next-generation sequencing protocol for identification and sequence-based prediction of pneumococcal serotypes. BMC Microbiol 14:60. http://dx.doi.org/10.1186/1471-2180-14-60.
260. Ip M, Liyanapathirana V, Ang I, Fung KS, Ng TK, Zhou H, Tsang DN. 2014. Direct detection and prediction of all pneumococcal serogroups by target enrichment-based next-generation sequencing. J Clin Microbiol 52:4244–4252. http://dx.doi.org/10.1128/JCM.02397-14.
261. Croucher NJ, Finkelstein JA, Pelton SI, Mitchell PK, Lee GM, Parkhill J, Bentley SD, Hanage WP, Lipsitch M. 2013. Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet 45: 656–663. http://dx.doi.org/10.1038/ng.2625.
262. Bertelli C, Greub G. 2013. Rapid bacterial genome sequencing: methods and applications in clinical microbiology. Clin Microbiol Infect 19:803–813. http://dx.doi.org/10.1111/1469-0691.12217.
263. Everett DB, Cornick J, Denis B, Chewapreecha C, Croucher N, Harris S, Parkhill J, Gordon S, Carrol ED, French N, Heyderman RS, Bentley SD. 2012. Genetic characterisation of Malawian pneumococci prior to the roll-out of the PCV13 vaccine using a high-throughput whole genome sequencing approach. PLoS One 7:e44250. http://dx.doi.org/10.1371/journal.pone.0044250.
264. Hilty M, Wuthrich D, Salter SJ, Engel H, Campbell S, Sa-Leao R, de Lencastre H, Hermans P, Sadowy E, Turner P, Chewapreecha C, Diggle M, Pluschke G, McGee L, Koseoglu Eser O, Low DE, Smith- Vaughan H, Endimiani A, Kuffer M, Dupasquier M, Beaudoing E, Weber J, Bruggmann R, Hanage WP, Parkhill J, Hathaway LJ, Muhlemann K, Bentley SD. 2014. Global phylogenomic analysis of nonencapsulated Streptococcus pneumoniae reveals a deep-branching classic lineage that is distinct from multiple sporadic lineages. Genome Biol Evol 6:3281–3294. http://dx.doi.org/10.1093/gbe/evu263.
265. Carvalho MDG, Pimenta FC, Moura I, Roundtree A, Gertz RE, Jr, Li Z, Jagero G, Bigogo G, Junghae M, Conklin L, Feikin DR, Breiman RF, Whitney CG, Beall BW. 2013. Non-pneumococcal mitis-group streptococci confound detection of pneumococcal capsular serotype-specific loci in upper respiratory tract. PeerJ 1:e97. http://dx.doi.org/10.7717/peerj.97.
266. Pimenta FC, Gertz RE, Jr, Roundtree A, Yu J, Nahm MH, McDonald RR, Carvalho MDG, Beall BW. 2009. Rarely occurring 19A-like cps locus from a serotype 19F pneumococcal isolate indicates continued need of serology-based quality control for PCR-based serotype determinations. J Clin Microbiol 47:2353–2354. http://dx.doi.org/10.1128/JCM.00704-09.
267. Sheppard CL, Harrison TG, Smith MD, George RC. 2011. Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific Streptococcus pneumoniae antigen in urine samples. J Med Microbiol 60:49–55. http://dx.doi.org/10.1099/jmm.0.023150-0.
268. Pride MW, Huijts SM, Wu K, Souza V, Passador S, Tinder C, Song E, Elfassy A, McNeil L, Menton R, French R, Callahan J, Webber C, Gruber WC, Bonten MJ, Jansen KU. 2012. Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotypespecific polysaccharides in human urine. Clin Vaccine Immunol 19: 1131–1141. http://dx.doi.org/10.1128/CVI.00064-12.
269. Sherwin RL, Gray S, Alexander R, McGovern PC, Graepel J, Pride MW, Purdy J, Paradiso P, File TM, Jr. 2013. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged_50 years with community-acquired pneumonia. J Infect Dis 208:1813–1820. http://dx.doi.org/10.1093/infdis/jit506.
270. Yu J, Salamon D, Marcon M, Nahm MH. 2011. Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients. J Clin Microbiol 49:534–538. http://dx.doi.org/10.1128/JCM.01827-10.
271. Siira L, Kaijalainen T, Lambertsen L, Nahm MH, Toropainen M, Virolainen A. 2012. From quellung to multiplex PCR, and back when needed, in pneumococcal serotyping. J Clin Microbiol 50:2727–2731. http://dx.doi.org/10.1128/JCM.00689-12.
272. Lund E. 1970. On the nomenclature of the pneumococcal types. Int J Syst Bacteriol 20:321–323. http://dx.doi.org/10.1099/00207713-20-3-321.
273. Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, Rumke HC, Verbrugh HA, Hermans PW. 2004. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363:1871–1872. http://dx.doi.org/10.1016/S0140-6736(04)16357-5.
274. Spijkerman J, Prevaes SM, van Gils EJ, Veenhoven RH, Bruin JP, Bogaert D, Wijmenga-Monsuur AJ, van den Dobbelsteen GP, Sanders EA. 2012. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One 7:e39730. http://dx.doi.org/10.1371/journal.pone.0039730.
275. Caimano MJ, Hardy GG, Yother J. 1998. Capsule genetics in Streptococcus pneumoniae and a possible role for transposition in the generation of the type 3 locus. Microb Drug Resist 4:11–23. http://dx.doi.org/10.1089/mdr.1998.4.11.
276. Dillard JP, Yother J. 1994. Genetic and molecular characterization of capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 3. Mol Microbiol 12:959–972. http://dx.doi.org/10.1111/j.1365-2958.1994.tb01084.x.
277. Stroop CJ, Xu Q, Retzlaff M, Abeygunawardana C, Bush CA. 2002. Structural analysis and chemical depolymerization of the capsular polysaccharide of Streptococcus pneumoniae type 1. Carbohydr Res 337:335–344. http://dx.doi.org/10.1016/S0008-6215(01)00318-4.
278. Jones C, Currie F, Forster MJ. 1991. N.m.r. and conformational analysis of the capsular polysaccharide from Streptococcus pneumoniae type 4. Carbohydr Res 221:95–121. http://dx.doi.org/10.1016/0008-6215(91)80051-N.
279. Park IH, Geno KA, Yu J, Oliver MB, Kim KH, Nahm MH. 2015. Genetic, biochemical, and serological characterization of a new pneumococcal serotype, 6H, and generation of a pneumococcal strain producing three different capsular repeat units. Clin Vaccine Immunol 22:313–318. http://dx.doi.org/10.1128/CVI.00647-14.
280. Yang J, Shelat NY, Bush CA, Cisar JO. 2010. Structure and molecular characterization of Streptococcus pneumoniae capsular polysaccharide 10F by carbohydrate engineering in Streptococcus oralis. J Biol Chem 285:24217–24227. http://dx.doi.org/10.1074/jbc.M110.123562.
281. Yang J, Nahm MH, Bush CA, Cisar JO. 2011. Comparative structural and molecular characterization of Streptococcus pneumoniae capsular polysaccharide serogroup 10. J Biol Chem 286:35813–35822. http://dx.doi.org/10.1074/jbc.M111.255422.
282. Zartler ER, Porambo RJ, Anderson CL, Chen LH, Yu J, Nahm MH. 2009. Structure of the capsular polysaccharide of pneumococcal serotype 11A reveals a novel acetylglycerol that is the structural basis for 11A subtypes. J Biol Chem 284:7318–7329. http://dx.doi.org/10.1074/jbc.M807952200.
283. Jones C, Whitley C, Lemercinier X. 2000. Full assignment of the proton and carbon NMR spectra and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 17F. Carbohydr Res 325: 192–201. http://dx.doi.org/10.1016/S0008-6215(99)00331-6.
284. Jones C, Aguilera B, van Boom JH, Buchanan JG. 2002. Confirmation of the D configuration of the 2-substituted arabinitol 1-phosphate residue in the capsular polysaccharide from Streptococcus pneumoniae type 17F. Carbohydr Res 337:2353–2358. http://dx.doi.org/10.1016/S0008-6215(02)00185-4.
285. Lemercinier X, Jones C. 2006. Full assignment of the 1H and 13C spectra and revision of the O-acetylation site of the capsular polysaccharide of Streptococcus pneumoniae type 33F, a component of the current pneumococcal polysaccharide vaccine. Carbohydr Res 341:68–74. http://dx.doi.org/10.1016/j.carres.2005.10.014.
286. Lin FL, Vinogradov E, Deng C, Zeller S, Green BA, Jansen KU, Pavliak V. 2013. Identification of the common antigenic determinant shared by Streptococcus pneumoniae serotypes 33A, 35A, and 20 capsular polysaccharides. Carbohydr Res 380:101–107. http://dx.doi.org/10.1016/j.carres.2013.08.001.
287. Petersen BO, Meier S, Paulsen BS, Redondo AR, Skovsted IC. 2014. Determination of native capsular polysaccharide structures of Streptococcus pneumoniae serotypes 39, 42, and 47F and comparison to genetically or serologically related strains. Carbohydr Res 395:38–46. http://dx.doi.org/10.1016/j.carres.2014.06.018.
288. Petersen BO, Skovsted IC, Paulsen BS, Redondo AR, Meier S. 2014. Structural determination of Streptococcus pneumoniae repeat units in serotype 41A and 41F capsular polysaccharides to probe gene functions in the corresponding capsular biosynthetic loci. Carbohydr Res 400:26–32. http://dx.doi.org/10.1016/j.carres.2014.08.017.
289. Petersen BO, Hindsgaul O, Paulsen BS, Redondo AR, Skovsted IC. 2014. Structural elucidation of the capsular polysaccharide from Streptococcus pneumoniae serotype 47A byNMRspectroscopy. Carbohydr Res 386:62–67. http://dx.doi.org/10.1016/j.carres.2013.11.013.
290. Bush CA, Cisar JO, Yang J. 8 June 2015. Structures of capsular polysaccharide serotypes 35F and 35C of Streptococcus pneumoniae determined by nuclear magnetic resonance and their relation to other cross-reactive serotypes. J Bacteriol http://dx.doi.org/10.1128/JB.00207-15.